Two Sigma Advisers, LP
- SEC CIK
- 0001478735
- Latest filing
- Aug 14, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −98,360−100.0% | Sold out | Holders |
| Q4 2025 | 98,360 | $44.6M | 0.1% | +86,860+755.3% | Added | Holders |
| Q3 2025 | 11,500 | $4.50M | <0.1% | +10,600+1,177.8% | Added | Holders |
| Q2 2025 | 900 | $400.7K | <0.1% | +900 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −3,200−100.0% | Sold out | Holders |
| Q4 2024 | 3,200 | $1.29M | <0.1% | −26,200−89.1% | Reduced | Holders |
| Q3 2024 | 29,400 | $13.7M | <0.1% | −142,400−82.9% | Reduced | Holders |
| Q2 2024 | 171,800 | $80.5M | 0.2% | +49,800+40.8% | Added | Holders |
| Q1 2024 | 122,000 | $51.0M | 0.1% | +34,500+39.4% | Added | Holders |
| Q4 2023 | 87,500 | $35.6M | 0.1% | −55,900−39.0% | Reduced | Holders |
| Q3 2023 | 143,400 | $49.9M | 0.1% | −71,000−33.1% | Reduced | Holders |
| Q2 2023 | 214,400 | $75.4M | 0.2% | +154,000+255.0% | Added | Holders |
| Q1 2023 | 60,400 | $19.0M | <0.1% | +42,600+239.3% | Added | Holders |
| Q4 2022 | 17,800 | $5.14M | <0.1% | −5,200−22.6% | Reduced | Holders |
| Q3 2022 | 23,000 | $6.66M | <0.1% | −1,700−6.9% | Reduced | Holders |
| Q2 2022 | 24,700 | $6.96M | <0.1% | +6,900+38.8% | Added | Holders |
| Q1 2022 | 17,800 | $4.64M | <0.1% | +5,500+44.7% | Added | Holders |
| Q4 2021 | 12,300 | $2.70M | <0.1% | −770,400−98.4% | Reduced | Holders |
| Q3 2021 | 782,700 | $142.0M | 0.4% | +781,700+78,170.0% | Added | Holders |
| Q2 2021 | 1,000 | $202.0K | <0.1% | +1,000 | New | Holders |